Renal Cancers Terminated Phase 2 Trials for Sunitinib (DB01268)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00853125Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney CancerTreatment